1. Home
  2. WEX vs ALKS Comparison

WEX vs ALKS Comparison

Compare WEX & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEX
  • ALKS
  • Stock Information
  • Founded
  • WEX 1983
  • ALKS 1987
  • Country
  • WEX United States
  • ALKS Ireland
  • Employees
  • WEX N/A
  • ALKS N/A
  • Industry
  • WEX Business Services
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEX Consumer Discretionary
  • ALKS Health Care
  • Exchange
  • WEX Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • WEX 5.8B
  • ALKS 5.0B
  • IPO Year
  • WEX 2005
  • ALKS 1991
  • Fundamental
  • Price
  • WEX $145.33
  • ALKS $32.81
  • Analyst Decision
  • WEX Hold
  • ALKS Strong Buy
  • Analyst Count
  • WEX 13
  • ALKS 13
  • Target Price
  • WEX $172.92
  • ALKS $42.31
  • AVG Volume (30 Days)
  • WEX 396.3K
  • ALKS 2.7M
  • Earning Date
  • WEX 10-29-2025
  • ALKS 10-28-2025
  • Dividend Yield
  • WEX N/A
  • ALKS N/A
  • EPS Growth
  • WEX N/A
  • ALKS 2.44
  • EPS
  • WEX 7.64
  • ALKS 2.02
  • Revenue
  • WEX $2,624,500,000.00
  • ALKS $1,521,338,000.00
  • Revenue This Year
  • WEX $1.59
  • ALKS N/A
  • Revenue Next Year
  • WEX $4.91
  • ALKS $24.60
  • P/E Ratio
  • WEX $19.05
  • ALKS $16.31
  • Revenue Growth
  • WEX N/A
  • ALKS 1.08
  • 52 Week Low
  • WEX $110.45
  • ALKS $25.17
  • 52 Week High
  • WEX $191.43
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • WEX 37.30
  • ALKS 64.15
  • Support Level
  • WEX $142.19
  • ALKS $30.66
  • Resistance Level
  • WEX $150.84
  • ALKS $36.32
  • Average True Range (ATR)
  • WEX 5.47
  • ALKS 1.66
  • MACD
  • WEX -0.69
  • ALKS 0.08
  • Stochastic Oscillator
  • WEX 14.75
  • ALKS 55.25

About WEX WEX Inc. common stock

WEX Inc is a provider of corporate payment solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. The company's prime end market is the United States of America.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: